PTCT

PTC Therapeutics, Inc. is a leading biopharmaceutical company headquartered in South Plainfield, New Jersey, specializing in the development of innovative therapies for rare genetic disorders. With a strong emphasis on RNA modulation and small molecule therapeutics, PTC has built a compelling pipeline of product candidates that address critical unmet medical needs. The company's commitment to transformative treatments establishes it as a significant player in the rare disease market, where its pioneering solutions aim to enhance patient outcomes and address the challenges faced by those with serious, underserved conditions.